rac-3-(1-(5-bromo-4-(4-(trifluoromethyl)phenyl)oxazol-2-yl)-2-(5-methyl-1,3,4-oxadiazol-2-yl)ethoxy)-2,6-difluorobenzamide

ID: ALA3098684

PubChem CID: 72947707

Max Phase: Preclinical

Molecular Formula: C22H14BrF5N4O4

Molecular Weight: 573.27

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1nnc(CC(Oc2ccc(F)c(C(N)=O)c2F)c2nc(-c3ccc(C(F)(F)F)cc3)c(Br)o2)o1

Standard InChI:  InChI=1S/C22H14BrF5N4O4/c1-9-31-32-15(34-9)8-14(35-13-7-6-12(24)16(17(13)25)20(29)33)21-30-18(19(23)36-21)10-2-4-11(5-3-10)22(26,27)28/h2-7,14H,8H2,1H3,(H2,29,33)

Standard InChI Key:  SPZSYUHLFVIQFN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   25.0674  -13.1039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0662  -13.9234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7743  -14.3324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4839  -13.9230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4811  -13.1003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7725  -12.6951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3596  -12.6955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3594  -11.8783    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.6520  -13.1043    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.3582  -14.3315    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   25.7700  -11.8779    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   27.1873  -12.6891    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.8965  -13.0950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6027  -12.6837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3521  -13.0181    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.6867  -11.8755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.4853  -11.7025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8953  -12.4095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8144  -10.9570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6281  -10.8704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9583  -10.1237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4759   -9.4630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6595   -9.5539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3330  -10.3007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8051   -8.7151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6174   -8.6262    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.3219   -8.0560    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.0120   -7.9202    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.7083  -12.4924    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   27.8996  -13.9122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6088  -14.3181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6978  -15.1271    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.4977  -15.2939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9037  -14.5846    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.3545  -13.9795    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.8329  -16.0392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  2  0
  7  9  1  0
  2 10  1  0
  6 11  1  0
  5 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 18  1  0
 17 16  1  0
 16 14  2  0
 17 18  2  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 17 19  1  0
 22 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
 18 29  1  0
 13 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 31  2  0
 33 36  1  0
M  END

Associated Targets(non-human)

ftsZ Cell division protein ftsZ (380 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 573.27Molecular Weight (Monoisotopic): 572.0119AlogP: 5.55#Rotatable Bonds: 7
Polar Surface Area: 117.27Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.96CX Basic pKa: CX LogP: 3.42CX LogD: 3.42
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.29Np Likeness Score: -1.19

References

1. Stokes NR, Baker N, Bennett JM, Chauhan PK, Collins I, Davies DT, Gavade M, Kumar D, Lancett P, Macdonald R, Macleod L, Mahajan A, Mitchell JP, Nayal N, Nayal YN, Pitt GR, Singh M, Yadav A, Srivastava A, Czaplewski LG, Haydon DJ..  (2014)  Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZ.,  24  (1): [PMID:24287381] [10.1016/j.bmcl.2013.11.002]

Source